Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod for Acute Stroke
NCT02002390Phase 2Completed
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in ischemic stroke, intracerebral hemorrhage (ICH), sponsored by Tianjin Medical University General Hospital. Started Oct 2012; status: completed.
02
Drugs
fingolimod
03
Conditions
ischemic strokeintracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT02002390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002390.